Literature DB >> 4401017

Immunologic reconstitution in severe combined immunodeficiency wihout bone-marrow chromosomal chimerism.

E R Stiehm, G J Lawlor, M S Kaplan, H L Greenwald, R C Neerhout, D P Sengar, P I Terasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4401017     DOI： 10.1056/NEJM197204132861501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease.

Authors:  B Löwenberg; J M Vossen; L J Dooren
Journal:  Blut       Date:  1977-03

2.  Extraneous HLA antigens in severe combined immunodeficiency disease (scid). Survey of the literature and report of one new case.

Authors:  K G Evers; J Krüger; R Hägele
Journal:  Eur J Pediatr       Date:  1977-04-26       Impact factor: 3.183

3.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

4.  Homogeneous immunoglobulins in sera of rhesus monkeys after lethal irradiation and bone marrow transplantation.

Authors:  J Rádl; P van den Berg; M Voormolen; W D Hendriks; U W Schaefer
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

5.  Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977.

Authors:  A B Kenny; W H Hitzig
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

6.  Genetic markers in human bone marrow transplantation.

Authors:  K G Blume; E Beutler; K J Bross; G M Schmidt; W E Spruce; R L Teplitz
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  Intact B-Cell Signaling and Function With Host B-Cells 47 Years After Transplantation for X-SCID.

Authors:  Christin Deal; Timothy J Thauland; E Richard Stiehm; Maria I Garcia-Lloret; Manish J Butte
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.